Global Recombinant Protein Drugs Sales Market Report 2018

Publisher Name :
Date: 03-May-2018
No. of pages: 111
Inquire Before Buying

This report studies the global Recombinant Protein Drugs market status and forecast, categorizes the global Recombinant Protein Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

In 2017, the global Recombinant Protein Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major players covered in this report

- Novo Nordisk

- Amgen

- Sanofi

- Eli Lilly

- Merck Serono

- Ortho Biotech

- Roche

- Kyowa Hakko Kirin

- Pharmingen

- Abcam

- GenSci

- SL PHARM

- Dongbao Pharm

- Ankebio

- NCPC

- Heng Rui

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

The regional scope of the study is as follows:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Recombinant DNA

- Recombinant RNA

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Pharmaceutical Industry

- Other

The study objectives of this report are:

- To analyze and study the global Recombinant Protein Drugs sales, value, status (2013-2017) and forecast (2018-2025);

- To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.

- Focuses on the key Recombinant Protein Drugs players, to study the sales, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Recombinant Protein Drugs are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Recombinant Protein Drugs Manufacturers

Recombinant Protein Drugs Distributors/Traders/Wholesalers

Recombinant Protein Drugs Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Recombinant Protein Drugs market, by end-use.

Detailed analysis and profiles of additional market players.

Global Recombinant Protein Drugs Sales Market Report 2018

Table of Contents
Global Recombinant Protein Drugs Sales Market Report 2018
1 Recombinant Protein Drugs Market Overview
1.1 Product Overview and Scope of Recombinant Protein Drugs
1.2 Classification of Recombinant Protein Drugs by Product Category
1.2.1 Global Recombinant Protein Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Recombinant Protein Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Recombinant DNA
1.2.4 Recombinant RNA
1.3 Global Recombinant Protein Drugs Market by Application/End Users
1.3.1 Global Recombinant Protein Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Pharmaceutical Industry
1.3.3 Other
1.4 Global Recombinant Protein Drugs Market by Region
1.4.1 Global Recombinant Protein Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Recombinant Protein Drugs Status and Prospect (2013-2025)
1.4.3 Europe Recombinant Protein Drugs Status and Prospect (2013-2025)
1.4.4 China Recombinant Protein Drugs Status and Prospect (2013-2025)
1.4.5 Japan Recombinant Protein Drugs Status and Prospect (2013-2025)
1.4.6 Southeast Asia Recombinant Protein Drugs Status and Prospect (2013-2025)
1.4.7 India Recombinant Protein Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Recombinant Protein Drugs (2013-2025)
1.5.1 Global Recombinant Protein Drugs Sales and Growth Rate (2013-2025)
1.5.2 Global Recombinant Protein Drugs Revenue and Growth Rate (2013-2025)
2 Global Recombinant Protein Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Recombinant Protein Drugs Market Competition by Players/Suppliers
2.1.1 Global Recombinant Protein Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Recombinant Protein Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Recombinant Protein Drugs (Volume and Value) by Type
2.2.1 Global Recombinant Protein Drugs Sales and Market Share by Type (2013-2018)
2.2.2 Global Recombinant Protein Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Recombinant Protein Drugs (Volume and Value) by Region
2.3.1 Global Recombinant Protein Drugs Sales and Market Share by Region (2013-2018)
2.3.2 Global Recombinant Protein Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Recombinant Protein Drugs (Volume) by Application
3 United States Recombinant Protein Drugs (Volume, Value and Sales Price)
3.1 United States Recombinant Protein Drugs Sales and Value (2013-2018)
3.1.1 United States Recombinant Protein Drugs Sales and Growth Rate (2013-2018)
3.1.2 United States Recombinant Protein Drugs Revenue and Growth Rate (2013-2018)
3.1.3 United States Recombinant Protein Drugs Sales Price Trend (2013-2018)
3.2 United States Recombinant Protein Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Recombinant Protein Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Recombinant Protein Drugs Sales Volume and Market Share by Application (2013-2018)
4 Europe Recombinant Protein Drugs (Volume, Value and Sales Price)
4.1 Europe Recombinant Protein Drugs Sales and Value (2013-2018)
4.1.1 Europe Recombinant Protein Drugs Sales and Growth Rate (2013-2018)
4.1.2 Europe Recombinant Protein Drugs Revenue and Growth Rate (2013-2018)
4.1.3 Europe Recombinant Protein Drugs Sales Price Trend (2013-2018)
4.2 Europe Recombinant Protein Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Recombinant Protein Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Recombinant Protein Drugs Sales Volume and Market Share by Application (2013-2018)
5 China Recombinant Protein Drugs (Volume, Value and Sales Price)
5.1 China Recombinant Protein Drugs Sales and Value (2013-2018)
5.1.1 China Recombinant Protein Drugs Sales and Growth Rate (2013-2018)
5.1.2 China Recombinant Protein Drugs Revenue and Growth Rate (2013-2018)
5.1.3 China Recombinant Protein Drugs Sales Price Trend (2013-2018)
5.2 China Recombinant Protein Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Recombinant Protein Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Recombinant Protein Drugs Sales Volume and Market Share by Application (2013-2018)
6 Japan Recombinant Protein Drugs (Volume, Value and Sales Price)
6.1 Japan Recombinant Protein Drugs Sales and Value (2013-2018)
6.1.1 Japan Recombinant Protein Drugs Sales and Growth Rate (2013-2018)
6.1.2 Japan Recombinant Protein Drugs Revenue and Growth Rate (2013-2018)
6.1.3 Japan Recombinant Protein Drugs Sales Price Trend (2013-2018)
6.2 Japan Recombinant Protein Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Recombinant Protein Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Recombinant Protein Drugs Sales Volume and Market Share by Application (2013-2018)
7 Southeast Asia Recombinant Protein Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Recombinant Protein Drugs Sales and Value (2013-2018)
7.1.1 Southeast Asia Recombinant Protein Drugs Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Recombinant Protein Drugs Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Recombinant Protein Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Recombinant Protein Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Recombinant Protein Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Recombinant Protein Drugs Sales Volume and Market Share by Application (2013-2018)
8 India Recombinant Protein Drugs (Volume, Value and Sales Price)
8.1 India Recombinant Protein Drugs Sales and Value (2013-2018)
8.1.1 India Recombinant Protein Drugs Sales and Growth Rate (2013-2018)
8.1.2 India Recombinant Protein Drugs Revenue and Growth Rate (2013-2018)
8.1.3 India Recombinant Protein Drugs Sales Price Trend (2013-2018)
8.2 India Recombinant Protein Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Recombinant Protein Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Recombinant Protein Drugs Sales Volume and Market Share by Application (2013-2018)
9 Global Recombinant Protein Drugs Players/Suppliers Profiles and Sales Data
9.1 Novo Nordisk
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Recombinant Protein Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Amgen
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Recombinant Protein Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Amgen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Sanofi
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Recombinant Protein Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Sanofi Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Eli Lilly
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Recombinant Protein Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Eli Lilly Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Merck Serono
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Recombinant Protein Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Merck Serono Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Ortho Biotech
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Recombinant Protein Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Roche
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Recombinant Protein Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Roche Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Kyowa Hakko Kirin
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Recombinant Protein Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Pharmingen
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Recombinant Protein Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Pharmingen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Abcam
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Recombinant Protein Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Abcam Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 GenSci
9.12 SL PHARM
9.13 Dongbao Pharm
9.14 Ankebio
9.15 NCPC
9.16 Heng Rui
10 Recombinant Protein Drugs Maufacturing Cost Analysis
10.1 Recombinant Protein Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Recombinant Protein Drugs
10.3 Manufacturing Process Analysis of Recombinant Protein Drugs
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Recombinant Protein Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2017
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Recombinant Protein Drugs Market Forecast (2018-2025)
14.1 Global Recombinant Protein Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Recombinant Protein Drugs Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Recombinant Protein Drugs Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Recombinant Protein Drugs Price and Trend Forecast (2018-2025)
14.2 Global Recombinant Protein Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Recombinant Protein Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Recombinant Protein Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Recombinant Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Recombinant Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Recombinant Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Recombinant Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Recombinant Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Recombinant Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Recombinant Protein Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Recombinant Protein Drugs Sales Forecast by Type (2018-2025)
14.3.2 Global Recombinant Protein Drugs Revenue Forecast by Type (2018-2025)
14.3.3 Global Recombinant Protein Drugs Price Forecast by Type (2018-2025)
14.4 Global Recombinant Protein Drugs Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Recombinant Protein Drugs
Figure Global Recombinant Protein Drugs Sales Volume Comparison (K Doses) by Type (2013-2025)
Figure Global Recombinant Protein Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Recombinant DNA Product Picture
Figure Recombinant RNA Product Picture
Figure Global Recombinant Protein Drugs Sales Comparison (K Doses) by Application (2013-2025)
Figure Global Sales Market Share of Recombinant Protein Drugs by Application in 2017
Figure Pharmaceutical Industry Examples
Table Key Downstream Customer in Pharmaceutical Industry
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Recombinant Protein Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Recombinant Protein Drugs Sales Volume (K Doses) and Growth Rate (2013-2025)
Figure Global Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Recombinant Protein Drugs Sales Volume (K Doses) (2013-2018)
Table Global Recombinant Protein Drugs Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table Global Recombinant Protein Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Recombinant Protein Drugs Sales Share by Players/Suppliers
Figure 2017 Recombinant Protein Drugs Sales Share by Players/Suppliers
Figure Global Recombinant Protein Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Recombinant Protein Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Recombinant Protein Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Recombinant Protein Drugs Revenue Share by Players
Table 2017 Global Recombinant Protein Drugs Revenue Share by Players
Table Global Recombinant Protein Drugs Sales (K Doses) and Market Share by Type (2013-2018)
Table Global Recombinant Protein Drugs Sales Share (K Doses) by Type (2013-2018)
Figure Sales Market Share of Recombinant Protein Drugs by Type (2013-2018)
Figure Global Recombinant Protein Drugs Sales Growth Rate by Type (2013-2018)
Table Global Recombinant Protein Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Recombinant Protein Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Recombinant Protein Drugs by Type (2013-2018)
Figure Global Recombinant Protein Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Recombinant Protein Drugs Sales Volume (K Doses) and Market Share by Region (2013-2018)
Table Global Recombinant Protein Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Recombinant Protein Drugs by Region (2013-2018)
Figure Global Recombinant Protein Drugs Sales Growth Rate by Region in 2017
Table Global Recombinant Protein Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Recombinant Protein Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Recombinant Protein Drugs by Region (2013-2018)
Figure Global Recombinant Protein Drugs Revenue Growth Rate by Region in 2017
Table Global Recombinant Protein Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Recombinant Protein Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Recombinant Protein Drugs by Region (2013-2018)
Figure Global Recombinant Protein Drugs Revenue Market Share by Region in 2017
Table Global Recombinant Protein Drugs Sales Volume (K Doses) and Market Share by Application (2013-2018)
Table Global Recombinant Protein Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Recombinant Protein Drugs by Application (2013-2018)
Figure Global Recombinant Protein Drugs Sales Market Share by Application (2013-2018)
Figure United States Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2013-2018)
Figure United States Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2013-2018)
Table United States Recombinant Protein Drugs Sales Volume (K Doses) by Players (2013-2018)
Table United States Recombinant Protein Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Recombinant Protein Drugs Sales Volume Market Share by Players in 2017
Table United States Recombinant Protein Drugs Sales Volume (K Doses) by Type (2013-2018)
Table United States Recombinant Protein Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Recombinant Protein Drugs Sales Volume Market Share by Type in 2017
Table United States Recombinant Protein Drugs Sales Volume (K Doses) by Application (2013-2018)
Table United States Recombinant Protein Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Recombinant Protein Drugs Sales Volume Market Share by Application in 2017
Figure Europe Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2013-2018)
Figure Europe Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2013-2018)
Table Europe Recombinant Protein Drugs Sales Volume (K Doses) by Players (2013-2018)
Table Europe Recombinant Protein Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Recombinant Protein Drugs Sales Volume Market Share by Players in 2017
Table Europe Recombinant Protein Drugs Sales Volume (K Doses) by Type (2013-2018)
Table Europe Recombinant Protein Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Recombinant Protein Drugs Sales Volume Market Share by Type in 2017
Table Europe Recombinant Protein Drugs Sales Volume (K Doses) by Application (2013-2018)
Table Europe Recombinant Protein Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Recombinant Protein Drugs Sales Volume Market Share by Application in 2017
Figure China Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2013-2018)
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2013-2018)
Table China Recombinant Protein Drugs Sales Volume (K Doses) by Players (2013-2018)
Table China Recombinant Protein Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Recombinant Protein Drugs Sales Volume Market Share by Players in 2017
Table China Recombinant Protein Drugs Sales Volume (K Doses) by Type (2013-2018)
Table China Recombinant Protein Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Recombinant Protein Drugs Sales Volume Market Share by Type in 2017
Table China Recombinant Protein Drugs Sales Volume (K Doses) by Application (2013-2018)
Table China Recombinant Protein Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Recombinant Protein Drugs Sales Volume Market Share by Application in 2017
Figure Japan Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2013-2018)
Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2013-2018)
Table Japan Recombinant Protein Drugs Sales Volume (K Doses) by Players (2013-2018)
Table Japan Recombinant Protein Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Recombinant Protein Drugs Sales Volume Market Share by Players in 2017
Table Japan Recombinant Protein Drugs Sales Volume (K Doses) by Type (2013-2018)
Table Japan Recombinant Protein Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Recombinant Protein Drugs Sales Volume Market Share by Type in 2017
Table Japan Recombinant Protein Drugs Sales Volume (K Doses) by Application (2013-2018)
Table Japan Recombinant Protein Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Recombinant Protein Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2013-2018)
Figure Southeast Asia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2013-2018)
Table Southeast Asia Recombinant Protein Drugs Sales Volume (K Doses) by Players (2013-2018)
Table Southeast Asia Recombinant Protein Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Recombinant Protein Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Recombinant Protein Drugs Sales Volume (K Doses) by Type (2013-2018)
Table Southeast Asia Recombinant Protein Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Recombinant Protein Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Recombinant Protein Drugs Sales Volume (K Doses) by Application (2013-2018)
Table Southeast Asia Recombinant Protein Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Recombinant Protein Drugs Sales Volume Market Share by Application in 2017
Figure India Recombinant Protein Drugs Sales (K Doses) and Growth Rate (2013-2018)
Figure India Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Recombinant Protein Drugs Sales Price (USD/Dose) Trend (2013-2018)
Table India Recombinant Protein Drugs Sales Volume (K Doses) by Players (2013-2018)
Table India Recombinant Protein Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Recombinant Protein Drugs Sales Volume Market Share by Players in 2017
Table India Recombinant Protein Drugs Sales Volume (K Doses) by Type (2013-2018)
Table India Recombinant Protein Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Recombinant Protein Drugs Sales Volume Market Share by Type in 2017
Table India Recombinant Protein Drugs Sales Volume (K Doses) by Application (2013-2018)
Table India Recombinant Protein Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Recombinant Protein Drugs Sales Volume Market Share by Application in 2017
Table Novo Nordisk Basic Information List
Table Novo Nordisk Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novo Nordisk Recombinant Protein Drugs Sales Growth Rate (2013-2018)
Figure Novo Nordisk Recombinant Protein Drugs Sales Global Market Share (2013-2018)
Figure Novo Nordisk Recombinant Protein Drugs Revenue Global Market Share (2013-2018)
Table Amgen Basic Information List
Table Amgen Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Amgen Recombinant Protein Drugs Sales Growth Rate (2013-2018)
Figure Amgen Recombinant Protein Drugs Sales Global Market Share (2013-2018)
Figure Amgen Recombinant Protein Drugs Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi Recombinant Protein Drugs Sales Growth Rate (2013-2018)
Figure Sanofi Recombinant Protein Drugs Sales Global Market Share (2013-2018
Figure Sanofi Recombinant Protein Drugs Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Eli Lilly Recombinant Protein Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly Recombinant Protein Drugs Sales Global Market Share (2013-2018)
Figure Eli Lilly Recombinant Protein Drugs Revenue Global Market Share (2013-2018)
Table Merck Serono Basic Information List
Table Merck Serono Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck Serono Recombinant Protein Drugs Sales Growth Rate (2013-2018)
Figure Merck Serono Recombinant Protein Drugs Sales Global Market Share (2013-2018)
Figure Merck Serono Recombinant Protein Drugs Revenue Global Market Share (2013-2018)
Table Ortho Biotech Basic Information List
Table Ortho Biotech Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Ortho Biotech Recombinant Protein Drugs Sales Growth Rate (2013-2018)
Figure Ortho Biotech Recombinant Protein Drugs Sales Global Market Share (2013-2018
Figure Ortho Biotech Recombinant Protein Drugs Revenue Global Market Share (2013-2018)
Table Roche Basic Information List
Table Roche Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Roche Recombinant Protein Drugs Sales Growth Rate (2013-2018)
Figure Roche Recombinant Protein Drugs Sales Global Market Share (2013-2018)
Figure Roche Recombinant Protein Drugs Revenue Global Market Share (2013-2018)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Sales Growth Rate (2013-2018)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Sales Global Market Share (2013-2018
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Revenue Global Market Share (2013-2018)
Table Pharmingen Basic Information List
Table Pharmingen Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Pharmingen Recombinant Protein Drugs Sales Growth Rate (2013-2018)
Figure Pharmingen Recombinant Protein Drugs Sales Global Market Share (2013-2018)
Figure Pharmingen Recombinant Protein Drugs Revenue Global Market Share (2013-2018)
Table Abcam Basic Information List
Table Abcam Recombinant Protein Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Abcam Recombinant Protein Drugs Sales Growth Rate (2013-2018)
Figure Abcam Recombinant Protein Drugs Sales Global Market Share (2013-2018)
Figure Abcam Recombinant Protein Drugs Revenue Global Market Share (2013-2018)
Table GenSci Basic Information List
Table SL PHARM Basic Information List
Table Dongbao Pharm Basic Information List
Table Ankebio Basic Information List
Table NCPC Basic Information List
Table Heng Rui Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Protein Drugs
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Figure Recombinant Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Protein Drugs Major Players in 2017
Table Major Buyers of Recombinant Protein Drugs
Table Distributors/Traders List
Figure Global Recombinant Protein Drugs Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Global Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Recombinant Protein Drugs Price (USD/Dose) and Trend Forecast (2018-2025)
Table Global Recombinant Protein Drugs Sales Volume (K Doses) Forecast by Regions (2018-2025)
Figure Global Recombinant Protein Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Recombinant Protein Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Recombinant Protein Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Recombinant Protein Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Recombinant Protein Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Recombinant Protein Drugs Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Recombinant Protein Drugs Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Europe Recombinant Protein Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Recombinant Protein Drugs Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Recombinant Protein Drugs Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Recombinant Protein Drugs Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Recombinant Protein Drugs Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure India Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Recombinant Protein Drugs Sales (K Doses) Forecast by Type (2018-2025)
Figure Global Recombinant Protein Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Recombinant Protein Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Recombinant Protein Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Recombinant Protein Drugs Price (USD/Dose) Forecast by Type (2018-2025)
Table Global Recombinant Protein Drugs Sales (K Doses) Forecast by Application (2018-2025)
Figure Global Recombinant Protein Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Tagetes Oil Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 24-Jun-2019        Price: US 2900 Onwards        Pages: 182
    The Tagetes Oil market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Tagetes Oil. Global Tagetes Oil industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, market size (sales, revenue, and growth ......
  • Global Legalized Cannabis Market Insights, Forecast to 2025
    Published: 24-Jun-2019        Price: US 3900 Onwards        Pages: 119
    Though cannabis is popular across the globe, it is an illegally utilized drug as its use for various purposes is banned by myriad governments worldwide. The product is referred by names such as marijuana and hemp. In fact, hemp is used for psychological disorders as it has non-psychotic effects on the patients. Marijuana is used for medical or therapeutic purpose as well as recreational use. The global Legalized Cannabis market is valued at xx million US$ in 2018 and will reach xx million......
  • propolis Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Jun-2019        Price: US 3000 Onwards        Pages: 135
    Propolis Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Propolis industry with a focus on the Chinese market. The report provides key statistics on the market status of the Propolis manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Propolis market covering all important ......
  • Pharmaceutical Intermediates Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Jun-2019        Price: US 3000 Onwards        Pages: 139
    Pharmaceutical Intermediates Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pharmaceutical Intermediates industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pharmaceutical Intermediates manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-202......
  • Pharmaceutical Excipients Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Jun-2019        Price: US 3000 Onwards        Pages: 140
    Pharmaceutical Excipients Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pharmaceutical Excipients industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pharmaceutical Excipients manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global ......
  • Pharma Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Jun-2019        Price: US 3000 Onwards        Pages: 138
    Pharma Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pharma industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pharma manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Pharma market covering all important paramete......
  • Global Veterinarian Supplement Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 24-Jun-2019        Price: US 3480 Onwards        Pages: 121
    Veterinary Calcium Supplements can enhance pet immunity and help pets stay healthy. Veterinary Calcium Supplements include fat supplements, protein supplements, minerals supplements, vitamin supplements, etc. These ingredients are available as chewable tablets or treats, liquids, powders, capsules and in pet food. Scope of the Report: The worldwide market for Veterinarian Supplement is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million......
  • Global Saccharomyces Boulardii Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 24-Jun-2019        Price: US 3480 Onwards        Pages: 115
    Saccharomyces Boulardii is a non-pathogenic probiotic yeast that acts as a temporary flora to protect the gastrointestinal tract and the beneficial organisms of the intestine and has been recognized as antidiarrhoeals, intestinal anti-inflammatory and anti-infective agent. Scope of the Report: The worldwide market for Saccharomyces Boulardii is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019,......
  • Global S-Adenosylmethionine (SAMe) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 24-Jun-2019        Price: US 3480 Onwards        Pages: 117
    S-Adenosylmethionine (SAMe) is a chemical compound made from methionine, an amino acid also found in protein-rich foods, and adenosine triphosphate (ATP), a nucleic acid and the product of some chemical reactions in body. Now it is a dietary supplement available in the United States. It has also been used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. Scope of the Report: The worldwide market for S-Adenosylmethionine ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs